We are live on ! Find out more
GGI

GordonMD Global Investments Portfolio holdings

AUM $207M
This Fund
S&P 500
This Quarter Est. Return
+32.82%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$139M
AUM Growth
–
Cap. Flow
+$136M
Cap. Flow %
97.46%
Top 10 Hldgs %
89.72%
Holding
13
New
13
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
KYTX icon
Kyverna Therapeutics
KYTX
+$32.6M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$19M
3
PYXS icon
Pyxis Oncology
PYXS
+$14.5M
4
RARE icon
Ultragenyx Pharmaceutical
RARE
+$10.8M
5
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$9.98M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KYTX icon
1
Kyverna Therapeutics
KYTX
$547M
$41.3M 29.6%
+4,391,818
New +$32.6M
TEVA icon
2
Teva Pharmaceuticals
TEVA
$44.4B
$24M 17.22%
+769,550
New +$19M
BLCO icon
3
Bausch + Lomb
BLCO
$6.16B
$10.5M 7.51%
+613,472
New +$9.73M
CRNX icon
4
Crinetics Pharmaceuticals
CRNX
$9B
$10.4M 7.48%
+224,135
New +$9.98M
AMGN icon
5
Amgen
AMGN
$239B
$7.6M 5.45%
+23,212
New +$7.36M
RARE icon
6
Ultragenyx Pharmaceutical
RARE
$2.61B
$7.57M 5.43%
+329,101
New +$10.8M
TSHA icon
7
Taysha Gene Therapies
TSHA
$2.02B
$7.32M 5.25%
+1,330,901
New +$6.46M
VIR icon
8
Vir Biotechnology
VIR
$1.81B
$5.61M 4.02%
+930,317
New +$5.54M
TARS icon
9
Tarsus Pharmaceuticals
TARS
$3.14B
$5.46M 3.91%
+66,680
New +$4.98M
INCY icon
10
Incyte
INCY
$26.3B
$5.38M 3.86%
+54,500
New +$5.27M
INSM icon
11
Insmed
INSM
$27.1B
$4.98M 3.57%
+28,587
New +$5.22M
PYXS icon
12
Pyxis Oncology
PYXS
$255M
$4.74M 3.4%
+4,121,870
New +$14.5M
CLDX icon
13
Celldex Therapeutics
CLDX
$3.24B
$4.63M 3.32%
+170,307
New +$4.49M

Similar funds

AWS
Aspen Wealth Strategies Arvada, Colorado $207M AUM 22.85% 1-Year Est. Return
OPF
Old Peak Finance Chapel Hill, North Carolina $207M AUM
AWP
Avid Wealth Partners San Antonio, Texas $207M AUM 29.44% 1-Year Est. Return
MKW
Mullaney, Keating & Wright Middletown, Connecticut $207M AUM 26.34% 1-Year Est. Return
SPI
Sutton Place Investors Katonah, New York $207M AUM 27.9% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
HI
Harrington Investments Napa, California $206M AUM 35.31% 1-Year Est. Return
HA
Hofer & Associates Thousand Oaks, California $207M AUM 15.48% 1-Year Est. Return

GordonMD Global Investments's Q4 2025 Portfolio in Review

Q4 2025 is the first quarter with a 13F filing on record for GordonMD Global Investments, which disclosed 13 positions worth $139M. Its ten largest holdings account for 90% of the portfolio.

Its largest position is Kyverna Therapeutics: 4,391,818 shares worth $41.3M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • GordonMD Global Investments's largest Q4 2025 buy was Kyverna Therapeutics: 4,391,818 shares worth $41.3M.
  • GordonMD Global Investments's ten largest holdings make up 90% of its $139M portfolio in Q4 2025.
  • GordonMD Global Investments disclosed 13 positions in Q4 2025, its first 13F filing on record.

Based on GordonMD Global Investments's 13F filing for Q4 2025, filed 17 Feb 2026.